Philip J Starkey Lewis
Overview
Explore the profile of Philip J Starkey Lewis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
667
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Haideri S, McKinnon A, Taylor A, Kirkwood P, Starkey Lewis P, ODuibhir E, et al.
NPJ Regen Med
. 2018 Jan;
2:31.
PMID: 29303159
[This corrects the article DOI: 10.1038/s41536-017-0017-0.].
12.
Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies
Scarfe L, Brillant N, Kumar J, Ali N, Alrumayh A, Amali M, et al.
NPJ Regen Med
. 2018 Jan;
2:28.
PMID: 29302362
Regenerative medicine therapies hold enormous potential for a variety of currently incurable conditions with high unmet clinical need. Most progress in this field to date has been achieved with cell-based...
13.
Haideri S, McKinnon A, Taylor A, Kirkwood P, Starkey Lewis P, ODuibhir E, et al.
NPJ Regen Med
. 2018 Jan;
2:14.
PMID: 29302350
Chronic liver injury can be caused by viral hepatitis, alcohol, obesity, and metabolic disorders resulting in fibrosis, hepatic scarring, and cirrhosis. Novel therapies are urgently required and previous work has...
14.
Campana L, Starkey Lewis P, Pellicoro A, Aucott R, Man J, ODuibhir E, et al.
J Immunol
. 2017 Dec;
200(3):1169-1187.
PMID: 29263216
The disposal of apoptotic bodies by professional phagocytes is crucial to effective inflammation resolution. Our ability to improve the disposal of apoptotic bodies by professional phagocytes is impaired by a...
15.
Sharkey J, Starkey Lewis P, Barrow M, Alwahsh S, Noble J, Livingstone E, et al.
Cytotherapy
. 2017 Feb;
19(4):555-569.
PMID: 28214127
Background Aims: Tracking cells during regenerative cytotherapy is crucial for monitoring their safety and efficacy. Macrophages are an emerging cell-based regenerative therapy for liver disease and can be readily labeled...
16.
Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic Syndrome
Alwahsh S, Dwyer B, Forbes S, Van Thiel D, Starkey Lewis P, Ramadori G
Int J Mol Sci
. 2017 Jan;
18(2).
PMID: 28134848
The role of the liver and the endocrine pancreas in development of hyperinsulinemia in different types of obesity remains unclear. Sedentary rats (160 g) were fed a low-fat-diet (LFD, chow...
17.
Oosthuyzen W, Scullion K, Ivy J, Morrison E, Hunter R, Starkey Lewis P, et al.
J Am Soc Nephrol
. 2016 Mar;
27(11):3345-3355.
PMID: 27020854
Extracellular vesicles (ECVs) facilitate intercellular communication along the nephron, with the potential to change the function of the recipient cell. However, it is not known whether this is a regulated...
18.
Kia R, Kelly L, Sison-Young R, Zhang F, Pridgeon C, Heslop J, et al.
Toxicol Sci
. 2014 Dec;
144(1):173-85.
PMID: 25527335
Emerging hepatic models for the study of drug-induced toxicity include pluripotent stem cell-derived hepatocyte-like cells (HLCs) and complex hepatocyte-non-parenchymal cellular coculture to mimic the complex multicellular interactions that recapitulate the...
19.
Starkey Lewis P, Dear J, Platt V, Simpson K, Craig D, Antoine D, et al.
Hepatology
. 2011 Nov;
54(5):1767-76.
PMID: 22045675
Unlabelled: New biomarkers of liver injury are required in the clinic and in preclinical pharmaceutical evaluation. Previous studies demonstrate that two liver-enriched microRNAs (miR-122 and miR-192) are promising biomarkers of...